The total number of records retrieved from this search are 16. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
IDOV_1162	Virus nameHerpes simplex virus	Virus strainFusOn-H2 strain	Virus genome typeDNA	Virus familyHerpesviridae	Virus genome modificationDouble fusogenic expressing EGFP and GALV.fus protein	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineRenal cell carcinoma cell line	Cell lineACHN	Concentration of cell line1.5E+3 cells per well	In-vitro toxicityNA	AssayTrypan blue staining	In-vitro virus concentration0.1 pfu/cell	In-vitro result50% cell survival after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID17487379
IDOV_1164	Virus nameHerpes simplex virus	Virus strainFusOn-H2 strain	Virus genome typeDNA	Virus familyHerpesviridae	Virus genome modificationDouble fusogenic expressing EGFP and GALV.fus protein	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineRenal cell carcinoma cell line	Cell lineACHN	Concentration of cell line1.5E+3 cells per well	In-vitro toxicityNA	AssayTrypan blue staining	In-vitro virus concentration0.1 pfu/cell	In-vitro result5% cell survival after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID17487379
IDOV_1166	Virus nameHerpes simplex virus	Virus strainFusOn-H2 strain	Virus genome typeDNA	Virus familyHerpesviridae	Virus genome modificationDouble fusogenic expressing EGFP and GALV.fus protein	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineRenal cell carcinoma cell line	Cell lineACHN	Concentration of cell line1.5E+3 cells per well	In-vitro toxicityNA	AssayTrypan blue staining	In-vitro virus concentration0.01pfu/cell	In-vitro result55% cell survival after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID17487379
IDOV_1168	Virus nameHerpes simplex virus	Virus strainFusOn-H2 strain	Virus genome typeDNA	Virus familyHerpesviridae	Virus genome modificationDouble fusogenic expressing EGFP and GALV.fus protein	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineRenal cell carcinoma cell line	Cell lineACHN	Concentration of cell line1.5E+3 cells per well	In-vitro toxicityNA	AssayTrypan blue staining	In-vitro virus concentration0.01pfu/cell	In-vitro result10% cell survival after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID17487379
IDOV_1371	Virus nameAdenovirus	Virus strainZD55-Ki67	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationExpressing Ki67 ShRNA	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman renal cacinoma cell line	Cell lineACHN	Concentration of cell line1.0E+5 cells per well	In-vitro toxicityNA	AssayCrystal violet staining	In-vitro virus concentration0.01 MOI	In-vitro resultCancer cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID18690204
IDOV_1372	Virus nameAdenovirus	Virus strainZD55-Ki67	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationExpressing Ki67 ShRNA	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman renal cacinoma cell line	Cell lineACHN	Concentration of cell line1.0E+5 cells per well	In-vitro toxicityNA	AssayCrystal violet staining	In-vitro virus concentration0.1 MOI	In-vitro result100% cell killing	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID18690204
IDOV_1373	Virus nameAdenovirus	Virus strainZD55-Ki67	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationExpressing Ki67 ShRNA	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman renal cacinoma cell line	Cell lineACHN	Concentration of cell line1.0E+5 cells per well	In-vitro toxicityNA	AssayCrystal violet staining	In-vitro virus concentration1 MOI	In-vitro result100% cell killing	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID18690204
IDOV_1374	Virus nameAdenovirus	Virus strainZD55-Ki67	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationExpressing Ki67 ShRNA	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman renal cacinoma cell line	Cell lineACHN	Concentration of cell line1.0E+5 cells per well	In-vitro toxicityNA	AssayCrystal violet staining	In-vitro virus concentration10 MOI	In-vitro result100% cell killing	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID18690204
IDOV_1375	Virus nameAdenovirus	Virus strainZD55-Ki67	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationExpressing Ki67 ShRNA	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman renal cacinoma cell line	Cell lineACHN	Concentration of cell line1.0E+5 cells per well	In-vitro toxicityNA	AssayCrystal violet staining	In-vitro virus concentration100 MOI	In-vitro result100% cell killing	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID18690204
IDOV_1381	Virus nameAdenovirus	Virus strainZD55-Ki67	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationExpressing Ki67 ShRNA	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman renal cacinoma cell line	Cell lineACHN	Concentration of cell line1.0E+5 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration1 MOI	In-vitro result90% cell survival after day 2	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID18690204
IDOV_1382	Virus nameAdenovirus	Virus strainZD55-Ki67	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationExpressing Ki67 ShRNA	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman renal cacinoma cell line	Cell lineACHN	Concentration of cell line1.0E+5 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result60% cell survival after day 3	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID18690204
IDOV_1383	Virus nameAdenovirus	Virus strainZD55-Ki67	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationExpressing Ki67 ShRNA	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman renal cacinoma cell line	Cell lineACHN	Concentration of cell line1.0E+5 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration100 MOI	In-vitro result20% cell survival after day 4	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID18690204
IDOV_1393	Virus nameAdenovirus	Virus strainZD55-hTERT	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationDeletion of E1B gene and addition of shRNA expressing hTERT	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineRenal cancer cell line	Cell lineACHN	Concentration of cell line1.0E+5 cells per well	In-vitro toxicityNA	AssayCrystal violet staining	In-vitro virus concentration0.1 MOI	In-vitro result100% cell survival after day 7	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID19029834
IDOV_1394	Virus nameAdenovirus	Virus strainZD55-hTERT	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationDeletion of E1B gene and addition of shRNA expressing hTERT	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineRenal cancer cell line	Cell lineACHN	Concentration of cell line1.0E+5 cells per well	In-vitro toxicityNA	AssayCrystal violet staining	In-vitro virus concentration1 MOI	In-vitro result100% cell survival after day 7	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID19029834
IDOV_1395	Virus nameAdenovirus	Virus strainZD55-hTERT	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationDeletion of E1B gene and addition of shRNA expressing hTERT	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineRenal cancer cell line	Cell lineACHN	Concentration of cell line1.0E+5 cells per well	In-vitro toxicityNA	AssayCrystal violet staining	In-vitro virus concentration10 MOI	In-vitro resultsome cells are viable after day 7	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID19029834
IDOV_1396	Virus nameAdenovirus	Virus strainZD55-hTERT	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationDeletion of E1B gene and addition of shRNA expressing hTERT	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineRenal cancer cell line	Cell lineACHN	Concentration of cell line1.0E+5 cells per well	In-vitro toxicityNA	AssayCrystal violet staining	In-vitro virus concentration100 MOI	In-vitro resultAll cells are killed after day 7	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID19029834